<DOC>
	<DOC>NCT02092025</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and efficacy of long-term use of azilsartan tablets (Azilva Tablets) in patients with hypertension in a routine clinical setting.</brief_summary>
	<brief_title>Azilsartan Tablets Special Drug Use Surveillance: Long-term Use</brief_title>
	<detailed_description>This surveillance was designed to evaluate the safety and efficacy of long-term use of azilsartan tablets (Azilva Tablets) in hypertensive patients in daily medical practice. The usual dosage for adult is 20 mg of azilsartan administered orally once daily. The dose can be adjusted according to the patient's age and condition. ,The maximum daily dose is 40 mg.</detailed_description>
	<criteria>Hypertensive patients 1. Patients with a history of hypersensitivity to any of the ingredients of Azilsartan 2. Patients who are pregnant or having possibilities of being pregnant</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Pharmacological therapy</keyword>
</DOC>